Scancell Holdings (FRA:SCP) COGS-to-Revenue : 0.00 (As of Oct. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Scancell Holdings COGS-to-Revenue?

Scancell Holdings's Cost of Goods Sold for the six months ended in Oct. 2023 was €0.00 Mil. Its Revenue for the six months ended in Oct. 2023 was €0.00 Mil.

Scancell Holdings's COGS to Revenue for the six months ended in Oct. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Scancell Holdings's Gross Margin % for the six months ended in Oct. 2023 was N/A%.

Scancell Holdings COGS-to-Revenue Historical Data

The historical data trend for Scancell Holdings's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scancell Holdings COGS-to-Revenue Chart

Scancell Holdings Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

COGS-to-Revenue

Get a 7-Day Free Trial

0.10

Scancell Holdings Semi-Annual Data
	Apr14	Oct14	Apr15	Oct15	Apr16	Oct16	Apr17	Oct17	Apr18	Oct18	Apr19	Oct19	Apr20	Oct20	Apr21	Oct21	Apr22	Oct22	Apr23	Oct23
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	0.10	-	-

Scancell Holdings COGS-to-Revenue Calculation

Scancell Holdings's COGS to Revenue for the fiscal year that ended in Apr. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.596	/	5.986
	=	0.10

Scancell Holdings's COGS to Revenue for the quarter that ended in Oct. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Scancell Holdings (FRA:SCP) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Scancell Holdings's Gross Margin % for the six months ended in Oct. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Scancell Holdings COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Scancell Holdings's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Scancell Holdings (FRA:SCP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scancell Holdings PLC (FRA:SCP) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

SCLP.GB:UK SCLP:UK

Address

Sanders Road, Unit 202, Bellhouse Building, Oxford Science Park, Oxford, GBR, OX4 4GD

Website

https://www.scancell.co.uk

Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. The company is exploiting the unrivalled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Its potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Its Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.

Scancell Holdings (FRA:SCP) Headlines

No Headlines